Actavis Labs Ut Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ACTAVIS LABS UT INC, and what generic and branded alternatives to ACTAVIS LABS UT INC drugs are available?
ACTAVIS LABS UT INC has twenty approved drugs.
There are four tentative approvals on ACTAVIS LABS UT INC drugs.
Drugs and US Patents for Actavis Labs Ut Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Actavis Labs Ut Inc | TESTOSTERONE | testosterone | GEL;TRANSDERMAL | 204570-002 | Jul 17, 2020 | AB2 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Actavis Labs Ut Inc | CLONIDINE | clonidine | SYSTEM;TRANSDERMAL | 090873-001 | May 6, 2014 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Actavis Labs Ut Inc | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | benzoyl peroxide; clindamycin phosphate | GEL;TOPICAL | 205128-001 | Jun 19, 2015 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Actavis Labs Ut Inc | TESTOSTERONE | testosterone | GEL;TRANSDERMAL | 076737-001 | Jan 27, 2006 | AB1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Actavis Labs Ut Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Actavis Labs Ut Inc | LOXITANE IM | loxapine hydrochloride | INJECTABLE;INJECTION | 018039-001 | Approved Prior to Jan 1, 1982 | 3,546,226 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.